A2ML1

alpha-2-macroglobulin like 1, the group of Alpha-2-macroglobulin family

Basic information

Region (hg38): 12:8822621-8887001

Previous symbols: [ "CPAMD9" ]

Links

ENSG00000166535NCBI:144568OMIM:610627HGNC:23336Uniprot:A8K2U0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Noonan syndrome (Supportive), mode of inheritance: AD
  • Noonan syndrome (Disputed Evidence), mode of inheritance: AD
  • Noonan syndrome (Limited), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Otitis media, susceptibility toADAllergy/Immunology/InfectiousIndividuals may have increased susceptibility to otitis media, and awareness may allow awareness leading to prompt diagnosis and treatment of otitis mediaAllergy/Immunology/Infectious26121085

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the A2ML1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the A2ML1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
5
clinvar
281
clinvar
10
clinvar
296
missense
603
clinvar
35
clinvar
17
clinvar
655
nonsense
1
clinvar
39
clinvar
1
clinvar
41
start loss
0
frameshift
30
clinvar
1
clinvar
2
clinvar
33
inframe indel
9
clinvar
9
splice donor/acceptor (+/-2bp)
27
clinvar
1
clinvar
28
splice region
28
35
3
66
non coding
10
clinvar
170
clinvar
157
clinvar
337
Total 0 1 723 488 187

Variants in A2ML1

This is a list of pathogenic ClinVar variants found in the A2ML1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-8822636-T-C not specified Likely benign (Jan 16, 2018)514943
12-8822660-T-A not specified • Otitis media, susceptibility to Benign/Likely benign (Jan 20, 2024)241912
12-8822661-C-T Otitis media, susceptibility to • Otitis media Likely pathogenic (Oct 30, 2018)617555
12-8822664-C-G Uncertain significance (Nov 10, 2020)646862
12-8822672-A-G not specified Benign/Likely benign (Jul 09, 2023)1297720
12-8822677-T-C not specified Uncertain significance (Mar 15, 2024)1794915
12-8822680-T-A not specified Uncertain significance (Sep 23, 2021)1301380
12-8822687-A-G Likely benign (Feb 12, 2020)2081802
12-8822695-C-A not specified Uncertain significance (Mar 24, 2024)918129
12-8822701-C-A Uncertain significance (Oct 16, 2020)1063512
12-8822701-CAGA-C Uncertain significance (Jul 10, 2022)2042917
12-8822703-G-A not specified Uncertain significance (May 15, 2023)2506102
12-8822706-G-A not specified Likely benign (Nov 02, 2022)2449320
12-8822712-C-A Uncertain significance (Dec 24, 2021)2057951
12-8822712-C-G not specified Conflicting classifications of pathogenicity (Jan 22, 2024)760642
12-8822713-C-T not specified Uncertain significance (Dec 16, 2019)929084
12-8822714-G-A Uncertain significance (Apr 19, 2023)2055109
12-8822714-G-C Uncertain significance (Dec 11, 2019)849889
12-8822722-T-C Likely benign (Aug 24, 2023)2965507
12-8823009-A-G Benign (Jun 19, 2018)561550
12-8823168-T-G Likely benign (Nov 15, 2021)1595153
12-8823173-CT-C not specified Conflicting classifications of pathogenicity (Mar 01, 2022)987849
12-8823178-A-G not specified • A2ML1-related disorder Benign/Likely benign (Nov 22, 2023)413824
12-8823186-T-TA Uncertain significance (Jan 29, 2024)2081446
12-8823187-A-G not specified Conflicting classifications of pathogenicity (Sep 18, 2023)654693

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
A2ML1protein_codingprotein_codingENST00000299698 3564530
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.61e-340.0208112756336117071247990.0495
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.3277667920.9670.00004149472
Missense in Polyphen183202.780.902442583
Synonymous-0.06723163141.000.00001772835
Loss of Function1.916381.60.7720.00000397960

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.1020.102
Ashkenazi Jewish0.06630.0666
East Asian0.004900.00491
Finnish0.03340.0332
European (Non-Finnish)0.05550.0552
Middle Eastern0.004900.00491
South Asian0.07000.0693
Other0.05680.0572

dbNSFP

Source: dbNSFP

Function
FUNCTION: Is able to inhibit all four classes of proteinases by a unique 'trapping' mechanism. This protein has a peptide stretch, called the 'bait region' which contains specific cleavage sites for different proteinases. When a proteinase cleaves the bait region, a conformational change is induced in the protein which traps the proteinase. The entrapped enzyme remains active against low molecular weight substrates (activity against high molecular weight substrates is greatly reduced). Following cleavage in the bait region a thioester bond is hydrolyzed and mediates the covalent binding of the protein to the proteinase (By similarity). Displays inhibitory activity against chymotrypsin, papain, thermolysin, subtilisin A and, to a lesser extent, elastase but not trypsin. May play an important role during desquamation by inhibiting extracellular proteases. {ECO:0000250|UniProtKB:P01023, ECO:0000269|PubMed:16298998}.;

Recessive Scores

pRec
0.0833

Intolerance Scores

loftool
0.960
rvis_EVS
2.42
rvis_percentile_EVS
98.53

Haploinsufficiency Scores

pHI
0.0600
hipred
N
hipred_score
0.145
ghis
0.382

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.155

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Gene ontology

Biological process
negative regulation of endopeptidase activity;regulation of endopeptidase activity
Cellular component
extracellular space;extracellular exosome
Molecular function
serine-type endopeptidase inhibitor activity;peptidase inhibitor activity